FDA.reportPublic FDA data

Application 202758

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SUMATRIPTAN SUCCINATESUMATRIPTAN SUCCINATEINJECTABLE;SUBCUTANEOUSEQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-1605SumatriptanSumatriptanA-S Medication SolutionsANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent
55150-173SumatriptanSumatriptanAuroMedics Pharma LLCANDACurrent